Secondary outcomes will be the post-operative biochemical levels of calcium and PTH, the development of clinical hypocalcemia (symptoms as reported by the patient) during post-operative hospital stay, and the ThyPRO-39 and EQ-5D-5L results at hospital discharge. The gene discussed is PTH; the disease is Hypocalcemia.